Clinical Trial Detail

NCT ID NCT03221400
Title PEN-866 in Patients With Advanced Solid Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Tarveda Therapeutics
Indications

rhabdomyosarcoma

triple-receptor negative breast cancer

lung small cell carcinoma

gastric adenocarcinoma

Ewing sarcoma

Advanced Solid Tumor

Therapies

STA-8666

Age Groups: senior adult

No variant requirements are available.